28469263|t|Estrogen deficiency accelerates lumbar facet joints arthritis
28469263|a|Dramatic increase in the prevalence of lumbar facet joint (LFJ) arthritis in women around the age of menopause indicates a protective role for estrogen in LFJ arthritis. To date, there is no evidence for this indication and the mechanism of such an effect remains poorly understood. In this study, ovariectomized (OVX) mice were used to mimic the estrogen - deficient status of post-menopausal women. Micro-CT and immunohistochemistry was employed to assess the morphological and molecular changes in ovariectomy - induced LFJ arthritis. The results show that the LFJ subchondral bone mass was significantly decreased in OVX mice, with increased cavities on the interface of the subchondral bone. Severe cartilage degradation was observed in ovariectomy - induced LFJ arthritis. Increased blood vessels and innervations were also found in degenerated LFJ, particularly in the subchondral bone area. 17β-Estradiol treatment efficiently suppressed LFJ subchondral bone turnover, markedly inhibited cartilage degradation, and increased blood vessel and nerve ending growth in degenerated LFJ in OVX mice. Our study reveals that estrogen is a key factor in regulating LFJ metabolism. Severe LFJ degeneration occurs when estrogen is absent in vivo. Collapsed subchondral bone may be the initiation of this process, and estrogen replacement therapy can effectively prevent degeneration of LFJ under estrogen - deficient conditions.
28469263	0	8	Estrogen	T103	UMLS:C0014939
28469263	32	51	lumbar facet joints	T082	UMLS:C0507372
28469263	52	61	arthritis	T038	UMLS:C0003864
28469263	101	119	lumbar facet joint	T082	UMLS:C0507372
28469263	121	124	LFJ	T082	UMLS:C0507372
28469263	126	135	arthritis	T038	UMLS:C0003864
28469263	139	144	women	T098	UMLS:C0043210
28469263	163	172	menopause	T038	UMLS:C0025320
28469263	205	213	estrogen	T103	UMLS:C0014939
28469263	217	220	LFJ	T082	UMLS:C0507372
28469263	221	230	arthritis	T038	UMLS:C0003864
28469263	353	358	study	T062	UMLS:C2603343
28469263	360	385	ovariectomized (OVX) mice	T204	UMLS:C0025929
28469263	409	417	estrogen	T103	UMLS:C0014939
28469263	440	455	post-menopausal	T038	UMLS:C0206159
28469263	456	461	women	T098	UMLS:C0043210
28469263	463	471	Micro-CT	T058	UMLS:C2350281
28469263	476	496	immunohistochemistry	T058	UMLS:C0021044
28469263	524	537	morphological	T082	UMLS:C0543482
28469263	563	574	ovariectomy	T058	UMLS:C0029936
28469263	585	588	LFJ	T082	UMLS:C0507372
28469263	589	598	arthritis	T038	UMLS:C0003864
28469263	626	629	LFJ	T082	UMLS:C0507372
28469263	630	651	subchondral bone mass	T201	UMLS:C0005938
28469263	683	691	OVX mice	T204	UMLS:C0025929
28469263	708	716	cavities	T082	UMLS:C0229984
28469263	741	757	subchondral bone	T017	UMLS:C0262950
28469263	766	775	cartilage	T017	UMLS:C0007301
28469263	804	815	ovariectomy	T058	UMLS:C0029936
28469263	826	829	LFJ	T082	UMLS:C0507372
28469263	830	839	arthritis	T038	UMLS:C0003864
28469263	851	864	blood vessels	T017	UMLS:C0005847
28469263	901	912	degenerated	T038	UMLS:C0011164
28469263	913	916	LFJ	T082	UMLS:C0507372
28469263	938	954	subchondral bone	T017	UMLS:C0262950
28469263	955	959	area	T082	UMLS:C0005898
28469263	961	974	17β-Estradiol	T103	UMLS:C0014912
28469263	975	984	treatment	T058	UMLS:C0087111
28469263	1008	1011	LFJ	T082	UMLS:C0507372
28469263	1012	1037	subchondral bone turnover	T033	UMLS:C0231544
28469263	1058	1067	cartilage	T017	UMLS:C0007301
28469263	1095	1107	blood vessel	T017	UMLS:C0005847
28469263	1112	1124	nerve ending	T017	UMLS:C0027747
28469263	1125	1131	growth	T038	UMLS:C0018270
28469263	1135	1146	degenerated	T038	UMLS:C0011164
28469263	1147	1150	LFJ	T082	UMLS:C0507372
28469263	1154	1162	OVX mice	T204	UMLS:C0025929
28469263	1168	1173	study	T062	UMLS:C2603343
28469263	1187	1195	estrogen	T103	UMLS:C0014939
28469263	1249	1252	LFJ	T082	UMLS:C0507372
28469263	1253	1265	degeneration	T038	UMLS:C0011164
28469263	1278	1286	estrogen	T103	UMLS:C0014939
28469263	1297	1304	in vivo	T082	UMLS:C1515655
28469263	1316	1332	subchondral bone	T017	UMLS:C0262950
28469263	1376	1404	estrogen replacement therapy	T058	UMLS:C0014935
28469263	1429	1441	degeneration	T038	UMLS:C0011164
28469263	1445	1448	LFJ	T082	UMLS:C0507372
28469263	1455	1463	estrogen	T103	UMLS:C0014939